CLINICAL OBSERVATIONS ON THE USE OF THEPHORIN (NU-1504) - A NEW ANTIHISTAMINIC AGENT

被引：0
|
作者：
REYNOLDS, JL
HORTON, BT
机构：
来源：
JOURNAL OF LABORATORY AND CLINICAL MEDICINE | 1947年 / 32卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：1545 / 1546
页数：2
相关论文
共 50 条
  • [41] REPORT ABOUT THE CLINICAL USE OF A NEW ANTIDIARRHEIC THERAPEUTIC AGENT ON THE BASIS OF HUMIC-ACID
    BARTELS, KP
    PRAKTISCHE TIERARZT, 1986, 67 (06): : 516 - 518
  • [42] CLINICAL USE OF TC-99M-DIPHOSPHONATE (HEDSPA) - NEW AGENT FOR SKELETAL IMAGING
    PENDERGRASS, HP
    POTSAID, MS
    CASTRONOVO, FP
    RADIOLOGY, 1973, 107 (03) : 557 - 562
  • [43] CLINICAL USE OF A NEW DIAGNOSTIC AGENT, METHOPYRAPONE (SU-4885), IN PITUITARY AND ADRENOCORTICAL DISORDERS
    GOLD, EM
    KENT, JR
    FORSHAM, PH
    ANNALS OF INTERNAL MEDICINE, 1961, 54 (02) : 175 - +
  • [44] New antiretroviral agent use affects prevalence of HIV drug resistance in clinical care populations
    Davy-Mendez, Thibaut
    Eron, Joseph J.
    Brunet, Laurence
    Zakharova, Oksana
    Dennis, Ann M.
    Napravnik, Sonia
    AIDS, 2018, 32 (17) : 2593 - 2603
  • [45] CLINICAL OBSERVATIONS ON USE OF A NEW ANTIRHEUMATIC COMBINATION IN MANAGEMENT OF PAINFUL OSTEO-ARTICULAR DISORDERS
    MASTANDREA, G
    MIGLIARI, M
    CLINICA TERAPEUTICA, 1974, 70 (06): : 539 - 544
  • [46] ANTIARRHYTHMIC PROFILE OF THE NEW CLASS IB-ANTIARRHYTHMIC AGENT BARUCAINIDE - EXPERIMENTAL AND 1ST CLINICAL OBSERVATIONS
    HAVERKAMP, W
    HINDRICKS, G
    HEUER, H
    ASCHE, KD
    WITHOFT, D
    GULKER, H
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1987, 10 (04): : 1014 - 1014
  • [47] OriseTM Gel, A New Submucosal Lifting Agent: Potential Clinical Complications of Its Use: A Case Series
    Colak, Yasar
    Hasan, Badar
    Tandon, Kanwarpreet
    Khan, Sikandar
    Wadhwa, Vaibhav
    Bejarano, Pablo
    Erim, Tolga
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S101 - S101
  • [48] VECURONIUM - A NEW NONDEPOLARIZING NEUROMUSCULAR-BLOCKING AGENT - CLINICAL-PHARMACOLOGY, PHARMACOKINETICS, CARDIOVASCULAR EFFECTS AND USE IN SPECIAL CLINICAL SITUATIONS - COMMENTARY
    SAVARESE, JJ
    PHARMACOTHERAPY, 1984, 4 (05): : 245 - 246
  • [49] 15-(ORTHO-I-123-PHENYL)-PENTADECANOIC ACID, A NEW MYOCARDIAL IMAGING AGENT FOR CLINICAL USE
    ANTAR, MA
    SPOHR, G
    HERZOG, HH
    KAISER, KP
    NOTOHAMIPRODJO, G
    VESTER, E
    SCHWARTZKOPF, B
    LOSSE, B
    MACHULLA, HJ
    SHREEVE, WW
    FEINENDEGEN, LE
    NUCLEAR MEDICINE COMMUNICATIONS, 1986, 7 (09) : 683 - 696
  • [50] First Experience of Clinical Use of New Class III Antiarrhythmic Agent Niferidil in Patients With Persistent Atrial Fibrillation and Flutter
    Yuricheva, Yu. A.
    Maykov, E. B.
    Sokolov, S. F.
    Klimenko, Yu. L.
    Kratskina, T. L.
    Tarasovskyi, G. S.
    Bildinov, O. A.
    Bakalov, S. A.
    Golitsyn, S. P.
    Beloshapko, G. G.
    Yushmanova, A. V.
    Rosenshtraukh, L. V.
    Chazov, E. I.
    KARDIOLOGIYA, 2011, 51 (01) : 55 - 64
12345